How soon can a patient undergo noncardiac surgery after receiving a drug-eluting stent?
Weitz
Howard H
HH
Department of Medicine, Jefferson Medical College of Thomas Jefferson University Philadelphia, PA 19107, USA. Howard.Weitz@jefferson.edu
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000075202:Contraindications; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D017239:Paclitaxel / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents; D013514:Surgical Procedures, Operative; D013997:Time Factors
D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D017239:Paclitaxel; D020123:Sirolimus